PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsmycosis fungoides
MeSH D009182 - mycosis fungoides
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D016410:T-cell lymphoma cutaneous
$
Success rate
D009182: 
Mycosis fungoides
D056267:Pagetoid reticulosis
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaDexamethasone Dexamethasone  1990-08-31   
Etoposide Etoposide  1994-02-10   
Methylprednisolone Methylprednisolone  2006-10-27   
Cyclophosphamide Neosar  1993-04-29   
Prednisolone Prednisolone  1999-05-28   
Prednisolone Prelone  1986-02-04   
Etoposide Toposar  1995-02-27   
Novast LaboratoriesMethylprednisolone Methylprednisolone  2019-01-09   
PadagisDexamethasone, Neomycin, Polymyxin b Neomycin Polymyxin B Sulfates Dexamethasone  1989-07-31   
Dexamethasone, Tobramycin Tobramycin Dexamethasone  2022-02-11   
Taro PharmaceuticalPrednisolone Flo-pred 2028-10-11 2008-01-17   
Dr Reddys LaboratoriesCyclophosphamide Cyclophosphamide 2036-02-15 2020-07-30   
Dexamethasone, Ciprofloxacin Ciprofloxacin Dexamethasone  2020-08-10   
Dexamethasone Dexamethasone  1986-04-09   
MylanDexamethasone Dexamethasone  2008-08-29   
Etoposide Etoposide  2001-09-19   
Methotrexate Methotrexate  1992-05-15   
RocheRibavirin, Peginterferon alfa-2a Pegasys Copegus  2004-06-04   
Interferon alfa-2a Roferon-A  1986-06-04   
CiplaCyclophosphamide Cyclophosphamide  2019-01-18   
SandozDexamethasone Dexamethasone  1985-01-16   
Dexamethasone, Neomycin, Polymyxin b Maxitrol  1984-05-22   
Methylprednisolone Methylprednisolone  1997-10-31   
Dexamethasone, Ciprofloxacin Ciprodex 2025-06-04 2003-07-18   
Cyclophosphamide Cyclophosphamide  2023-09-12   
Prednisolone Omnipred  1982-01-01   
Dexamethasone, Tobramycin Tobradex  1988-08-18   
Methotrexate Methotrexate  2009-03-31   
Genus LifesciencesPrednisolone, Sulfacetamide Sulfacetamide Prednisolone  1993-05-27   
1
2
3
4
5
6
...
13
>
Clinical Trials
Historical Success Rate
Phase 1
39%
18/46
Phase 2
7%
2/28
Phase 3
86%
25/29
Approved: 23Overall Success rate: 2%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
1
2
3
4
5
6
...
9
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use